{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:18:18Z","timestamp":1776453498860,"version":"3.51.2"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00125-025-06504-5","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:01:24Z","timestamp":1757484084000},"page":"2479-2498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-2678","authenticated-orcid":false,"given":"Francesco","family":"Giorgino","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3056-3640","authenticated-orcid":false,"given":"Fawaz","family":"Alzaid","sequence":"additional","affiliation":[]},{"given":"Anca","family":"Pantea Stoian","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-1194","authenticated-orcid":false,"given":"Juliana C. N.","family":"Chan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-2168","authenticated-orcid":false,"given":"Linong","family":"Ji","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-8012","authenticated-orcid":false,"given":"William","family":"Lumu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-6147","authenticated-orcid":false,"given":"Helard","family":"Manrique","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2868-0250","authenticated-orcid":false,"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-8864","authenticated-orcid":false,"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1033-8673","authenticated-orcid":false,"given":"Peter A.","family":"Senior","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-7687","authenticated-orcid":false,"given":"Daisuke","family":"Yabe","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-0949","authenticated-orcid":false,"given":"Sophia","family":"Zoungas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-0011","authenticated-orcid":false,"given":"Manuela","family":"Meireles","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-5233","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-8885","authenticated-orcid":false,"given":"Leszek","family":"Czupryniak","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"2","key":"6504_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/EURHEARTJ\/EHZ966","volume":"41","author":"TF L\u00fcscher","year":"2020","unstructured":"L\u00fcscher TF (2020) A revolution in diabetes care: novel drugs and new recommendations. Eur Heart J 41(2):195\u2013198. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ966","journal-title":"Eur Heart J"},{"issue":"12","key":"6504_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/1753-0407.13341","volume":"14","author":"ZT Bloomgarden","year":"2022","unstructured":"Bloomgarden ZT (2022) Diabetes epidemiology: analysis of trends over time. J Diabetes 14(12):790\u2013791. https:\/\/doi.org\/10.1111\/1753-0407.13341","journal-title":"J Diabetes"},{"key":"6504_CR3","unstructured":"IDF (2025) IDF diabetes atlas, 11th edn. Available from: https:\/\/diabetesatlas.org\/. Accessed 28 Feb 2025"},{"issue":"Suppl 1","key":"6504_CR4","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.2337\/dc25-S006","volume":"48","author":"NA ElSayed","year":"2025","unstructured":"ElSayed NA, McCoy RG, Aleppo G et al (2025) 6. Glycemic goals and hypoglycemia: standards of care in diabetes\u20142025. Diabetes Care 48(Suppl 1):S128\u2013S145. https:\/\/doi.org\/10.2337\/dc25-S006","journal-title":"Diabetes Care"},{"key":"6504_CR5","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","volume":"54","author":"M Cnop","year":"2005","unstructured":"Cnop M, Welsh N, Jonas J-C, J\u00f6 A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic-cell death in type 1 and type 2 diabetes many differences, few similarities. Diabetes 54:S97\u2013S107","journal-title":"Diabetes"},{"issue":"9","key":"6504_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG (2023) Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol 19(9):542\u2013554. https:\/\/doi.org\/10.1038\/s41574-023-00853-0","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"6504_CR7","doi-asserted-by":"publisher","first-page":"e43697","DOI":"10.7759\/CUREUS.43697","volume":"15","author":"F Sugandh","year":"2023","unstructured":"Sugandh F, Chandio M, Raveena F et al (2023) Advances in the management of diabetes mellitus: a focus on personalized medicine. Cureus 15(8):e43697. https:\/\/doi.org\/10.7759\/CUREUS.43697","journal-title":"Cureus"},{"issue":"6","key":"6504_CR8","doi-asserted-by":"publisher","first-page":"e0000583","DOI":"10.1371\/JOURNAL.PGPH.0000583","volume":"2","author":"E Charani","year":"2022","unstructured":"Charani E, Abimbola S, Pai M et al (2022) Funders: the missing link in equitable global health research? PLOS Global Public Health 2(6):e0000583. https:\/\/doi.org\/10.1371\/JOURNAL.PGPH.0000583","journal-title":"PLOS Global Public Health"},{"issue":"10467","key":"6504_CR9","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","volume":"404","author":"B Zhou","year":"2024","unstructured":"Zhou B, Rayner AW, Gregg EW et al (2024) Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet 404(10467):2077\u20132093. https:\/\/doi.org\/10.1016\/S0140-6736(24)02317-1","journal-title":"Lancet"},{"issue":"2","key":"6504_CR10","doi-asserted-by":"publisher","first-page":"e0192413","DOI":"10.1371\/JOURNAL.PONE.0192413","volume":"13","author":"PK Drain","year":"2018","unstructured":"Drain PK, Parker RA, Robine M, Holmes KK (2018) Global migration of clinical research during the era of trial registration. PLoS One 13(2):e0192413. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0192413","journal-title":"PLoS One"},{"issue":"6","key":"6504_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/FUNCTION\/ZQAB060","volume":"2","author":"OH Petersen","year":"2021","unstructured":"Petersen OH (2021) Inequality of research funding between different countries and regions is a serious problem for global science. Function 2(6):60. https:\/\/doi.org\/10.1093\/FUNCTION\/ZQAB060","journal-title":"Function"},{"issue":"1","key":"6504_CR12","doi-asserted-by":"publisher","first-page":"e000984","DOI":"10.1136\/bmjmed-2024-000984","volume":"3","author":"D Collister","year":"2024","unstructured":"Collister D, Song C, Ruzycki SM (2024) Fostering diversity in clinical trials: need for evidence and implementation to improve representation. BMJ Medicine 3(1):e000984. https:\/\/doi.org\/10.1136\/bmjmed-2024-000984","journal-title":"BMJ Medicine"},{"issue":"6","key":"6504_CR13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/J.BETH.2024.06.003","volume":"55","author":"BK Sahdra","year":"2024","unstructured":"Sahdra BK, King G, Payne JS et al (2024) Why research from lower- and middle-income countries matters to evidence-based intervention: a state of the science review of ACT research as an example. Behav Ther 55(6):1348\u20131363. https:\/\/doi.org\/10.1016\/J.BETH.2024.06.003","journal-title":"Behav Ther"},{"issue":"2","key":"6504_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/S00223-023-01151-7\/METRICS","volume":"114","author":"H Saloojee","year":"2024","unstructured":"Saloojee H, Pettifor JM (2024) Maximizing access and minimizing barriers to research in low- and middle-income countries: open access and health equity. Calcif Tissue Int 114(2):83\u201385. https:\/\/doi.org\/10.1007\/S00223-023-01151-7\/METRICS","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"6504_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/BMJEBM-2022-112126","volume":"29","author":"P Logullo","year":"2024","unstructured":"Logullo P, De Beyer JA, Kirtley S, Schl\u00fcssel MM, Collins GS (2024) Open access journal publication in health and medical research and open science: benefits, challenges and limitations. BMJ Evid Based Med 29(4):223\u2013228. https:\/\/doi.org\/10.1136\/BMJEBM-2022-112126","journal-title":"BMJ Evid Based Med"},{"issue":"4","key":"6504_CR16","doi-asserted-by":"publisher","first-page":"e077132","DOI":"10.1136\/BMJOPEN-2023-077132","volume":"14","author":"L Gumber","year":"2024","unstructured":"Gumber L, Agbeleye O, Inskip A et al (2024) Operational complexities in international clinical trials: a systematic review of challenges and proposed solutions. BMJ Open 14(4):e077132. https:\/\/doi.org\/10.1136\/BMJOPEN-2023-077132","journal-title":"BMJ Open"},{"issue":"12","key":"6504_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.4155\/bio.11.135","volume":"3","author":"S Lowes","year":"2011","unstructured":"Lowes S, Jersey J, Shoup R et al (2011) Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis. Bioanalysis 3(12):1323\u20131332. https:\/\/doi.org\/10.4155\/bio.11.135","journal-title":"Bioanalysis"},{"issue":"7654","key":"6504_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/545289b","volume":"545","author":"J Demotes-Mainard","year":"2017","unstructured":"Demotes-Mainard J (2017) Global health: boost multinational clinical research. Nature 545(7654):289\u2013289. https:\/\/doi.org\/10.1038\/545289b","journal-title":"Nature"},{"key":"6504_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","volume":"17","author":"C Alemayehu","year":"2018","unstructured":"Alemayehu C, Mitchell G, Nikles J (2018) Barriers for conducting clinical trials in developing countries- a systematic review. Int J Equity Health 17:37","journal-title":"Int J Equity Health"},{"key":"6504_CR20","unstructured":"Clinical Research Initiative for Global Health (n.d.) About CRIGH. Available from: https:\/\/crigh.org\/about-crigh. Accessed 7 Mar 2025"},{"key":"6504_CR21","unstructured":"European Cardiovascular Research Center (n.d.) ABILITY Diabetes Global. Available from: https:\/\/www.cerc-europe.org\/ability-diabetes-global\/. Accessed 28 Feb 2025"},{"key":"6504_CR22","unstructured":"BioSpace (2024) Omics-based clinical trials market size to Hit USD 70.92 billion by 2034. Available from: https:\/\/www.biospace.com\/press-releases\/omics-based-clinical-trials-market-size-to-hit-usd-70-92-billion-by-2034. Accessed 28 Feb 2025"},{"key":"6504_CR23","unstructured":"(n.d.) Big picture oncology through multi-omics Available from: https:\/\/www.nature.com\/articles\/d42473-020-00119-7. Accessed 28 Feb 2025"},{"issue":"20","key":"6504_CR24","doi-asserted-by":"publisher","first-page":"e174015","DOI":"10.1172\/JCI174015","volume":"133","author":"Y Drexler","year":"2023","unstructured":"Drexler Y, Fornoni A (2023) Adenine crosses the biomarker bridge: from \u2019omics to treatment in diabetic kidney disease. J Clin Invest 133(20):e174015. https:\/\/doi.org\/10.1172\/JCI174015","journal-title":"J Clin Invest"},{"issue":"20","key":"6504_CR25","doi-asserted-by":"publisher","first-page":"e170341","DOI":"10.1172\/JCI170341","volume":"133","author":"K Sharma","year":"2023","unstructured":"Sharma K, Zhang G, Hansen J et al (2023) Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients. J Clin Invest 133(20):e170341. https:\/\/doi.org\/10.1172\/JCI170341","journal-title":"J Clin Invest"},{"issue":"1","key":"6504_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-64846-3","volume":"14","author":"T R\u00f6nn","year":"2024","unstructured":"R\u00f6nn T, Perfilyev A, Oskolkov N, Ling C (2024) Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets. Sci Rep 14(1):1\u201317. https:\/\/doi.org\/10.1038\/s41598-024-64846-3","journal-title":"Sci Rep"},{"issue":"5","key":"6504_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/S00125-024-06105-8","volume":"67","author":"RC Slieker","year":"2024","unstructured":"Slieker RC, M\u00fcnch M, Donnelly LA et al (2024) An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study. Diabetologia 67(5):885\u2013894. https:\/\/doi.org\/10.1007\/S00125-024-06105-8","journal-title":"Diabetologia"},{"key":"6504_CR28","doi-asserted-by":"publisher","unstructured":"(2023) Spatial Omics DataBase (SODB): increasing accessibility to spatial omics data. Nat Methods 20(3):359\u2013360. https:\/\/doi.org\/10.1038\/s41592-023-01772-8","DOI":"10.1038\/s41592-023-01772-8"},{"issue":"7727","key":"6504_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","volume":"562","author":"N Schaum","year":"2018","unstructured":"Schaum N, Karkanias J, Neff NF et al (2018) Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562(7727):367\u2013372. https:\/\/doi.org\/10.1038\/s41586-018-0590-4","journal-title":"Nature"},{"issue":"6594","key":"6504_CR30","doi-asserted-by":"publisher","first-page":"eabl4896","DOI":"10.1126\/science.abl4896","volume":"376","author":"RC Jones","year":"2022","unstructured":"The Tabula Sapiens Consortium, Jones RC, Karkanias J et al (2022) The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans. Science 376(6594):eabl4896. https:\/\/doi.org\/10.1126\/science.abl4896","journal-title":"Science"},{"key":"6504_CR31","doi-asserted-by":"publisher","unstructured":"Gan WZ, Ramachandran V, Lim CSY, Koh RY (2020) Omics-based biomarkers in the diagnosis of diabetes. J Basic Clin Physiol Pharmacol 31(2). https:\/\/doi.org\/10.1515\/jbcpp-2019-0120","DOI":"10.1515\/jbcpp-2019-0120"},{"issue":"4","key":"6504_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMP1006304","volume":"363","author":"MA Hamburg","year":"2010","unstructured":"Hamburg MA, Collins FS (2010) The path to personalized medicine. N Engl J Med 363(4):301\u2013304. https:\/\/doi.org\/10.1056\/NEJMP1006304","journal-title":"N Engl J Med"},{"issue":"10","key":"6504_CR33","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2337\/DBI20-0001","volume":"69","author":"E Ahlqvist","year":"2020","unstructured":"Ahlqvist E, Prasad RB, Groop L (2020) Subtypes of type 2 diabetes determined from clinical parameters. Diabetes 69(10):2086\u20132093. https:\/\/doi.org\/10.2337\/DBI20-0001","journal-title":"Diabetes"},{"issue":"8","key":"6504_CR34","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00125-024-06179-4","volume":"67","author":"G Fagherazzi","year":"2024","unstructured":"Fagherazzi G, Aguayo GA, Zhang L et al (2024) Heterogeneity of glycaemic phenotypes in type 1 diabetes. Diabetologia 67(8):1567\u20131581. https:\/\/doi.org\/10.1007\/s00125-024-06179-4","journal-title":"Diabetologia"},{"key":"6504_CR35","unstructured":"AstraZeneca (n.d.) Open Innovation: accelerating research and scientific innovation through collaboration. Available from: https:\/\/openinnovation.astrazeneca.com\/. Accessed 28 Feb 2025"},{"issue":"1","key":"6504_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12913-020-05435-8","volume":"20","author":"S Fanelli","year":"2020","unstructured":"Fanelli S, Salvatore FP, De Pascale G, Faccilongo N (2020) Insights for the future of health system partnerships in low- and middle-income countries: a systematic literature review. BMC Health Serv Res 20(1):571. https:\/\/doi.org\/10.1186\/s12913-020-05435-8","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"6504_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41437-020-0303-2","volume":"124","author":"R Agrawal","year":"2020","unstructured":"Agrawal R, Prabakaran S (2020) Big data in digital healthcare: lessons learnt and recommendations for general practice. Heredity 124(4):525\u2013534. https:\/\/doi.org\/10.1038\/s41437-020-0303-2","journal-title":"Heredity"},{"issue":"1","key":"6504_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41591-019-0727-5","volume":"26","author":"S Shilo","year":"2020","unstructured":"Shilo S, Rossman H, Segal E (2020) Axes of a revolution: challenges and promises of big data in healthcare. Nat Med 26(1):29\u201338. https:\/\/doi.org\/10.1038\/s41591-019-0727-5","journal-title":"Nat Med"},{"issue":"7","key":"6504_CR39","doi-asserted-by":"publisher","first-page":"e1002195","DOI":"10.1371\/journal.pbio.1002195","volume":"13","author":"ZD Stephens","year":"2015","unstructured":"Stephens ZD, Lee SY, Faghri F et al (2015) Big data: astronomical or genomical? PLoS Biol 13(7):e1002195. https:\/\/doi.org\/10.1371\/journal.pbio.1002195","journal-title":"PLoS Biol"},{"key":"6504_CR40","unstructured":"Organisation for Economic Cooperation and Development (n.d.) Digital health. Available from: https:\/\/www.oecd.org\/en\/topics\/policy-issues\/digital-health.html. Accessed 28 Feb 2025"},{"issue":"1","key":"6504_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-84003-0","volume":"15","author":"E Healey","year":"2025","unstructured":"Healey E, Tan ALM, Flint KL, Ruiz JL, Kohane I (2025) A case study on using a large language model to analyze continuous glucose monitoring data. Sci Rep 15(1):1\u20137. https:\/\/doi.org\/10.1038\/s41598-024-84003-0","journal-title":"Sci Rep"},{"key":"6504_CR42","doi-asserted-by":"publisher","first-page":"1399992","DOI":"10.3389\/FDGTH.2024.1399992","volume":"6","author":"TR Katapally","year":"2024","unstructured":"Katapally TR (2024) It\u2019s late, but not too late to transform health systems: a global digital citizen science observatory for local solutions to global problems. Front Digit Health 6:1399992. https:\/\/doi.org\/10.3389\/FDGTH.2024.1399992","journal-title":"Front Digit Health"},{"issue":"4","key":"6504_CR43","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.2196\/12712","volume":"7","author":"JG Shull","year":"2019","unstructured":"Shull JG (2019) Digital health and the state of interoperable electronic health records. JMIR Med Inform 7(4):e12712. https:\/\/doi.org\/10.2196\/12712","journal-title":"JMIR Med Inform"},{"key":"6504_CR44","unstructured":"World Bank Group (n.d.) Statistical performance indicators (SPI). Available from: https:\/\/www.worldbank.org\/en\/programs\/statistical-performance-indicators. Accessed 28 Feb 2025"},{"key":"6504_CR45","unstructured":"Gelvanovska-Garcia N, Rossotto CM, Ma\u010diul\u0117 V (2024) Bridging the digital divide: harnessing data through cloud computing. Available from: https:\/\/blogs.worldbank.org\/en\/digital-development\/bridging-the-digital-divide--harnessing-data-through-cloud-compu. Accessed 28 Feb 2025"},{"key":"6504_CR46","doi-asserted-by":"publisher","DOI":"10.2337\/DC24-2376","author":"AK Desouter","year":"2025","unstructured":"Desouter AK, Keymeulen B, Van de Velde U et al (2025) Repeated OGTT versus continuous glucose monitoring for predicting development of stage 3 type 1 diabetes: a longitudinal analysis. Diabetes Care. https:\/\/doi.org\/10.2337\/DC24-2376","journal-title":"Diabetes Care"},{"issue":"1","key":"6504_CR47","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/BMJDRC-2020-001190","volume":"8","author":"A Ahne","year":"2020","unstructured":"Ahne A, Orchard F, Tannier X et al (2020) Insulin pricing and other major diabetes-related concerns in the USA: a study of 46 407 tweets between 2017 and 2019. BMJ Open Diabetes Res Care 8(1):1190. https:\/\/doi.org\/10.1136\/BMJDRC-2020-001190","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"11","key":"6504_CR48","doi-asserted-by":"publisher","first-page":"e791","DOI":"10.1016\/S2589-7500(24)00172-9","volume":"6","author":"A Sau","year":"2024","unstructured":"Sau A, Pastika L, Sieliwonczyk E et al (2024) Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation study. Lancet Digit Health 6(11):e791\u2013e802. https:\/\/doi.org\/10.1016\/S2589-7500(24)00172-9","journal-title":"Lancet Digit Health"},{"key":"6504_CR49","unstructured":"European Union (2024) Regulation EU 2024\/1689. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32024R1689. Accessed 28 Feb 2025"},{"key":"6504_CR50","unstructured":"Ponomarov K (2024) Global AI regulations tracker: Europe, Americas & Asia-Pacific overview. Available from: https:\/\/legalnodes.com\/article\/global-ai-regulations-tracker. Accessed 28 Feb 2025"},{"key":"6504_CR51","unstructured":"NIH (n.d.) RePORT. Available from: https:\/\/report.nih.gov\/funding\/categorical-spending#\/. Accessed 28 Feb 2025"},{"issue":"1","key":"6504_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/DCI23-0085","volume":"47","author":"ED Parker","year":"2024","unstructured":"Parker ED, Lin J, Mahoney T et al (2024) Economic costs of diabetes in the U.S. in 2022. Diabetes Care 47(1):26\u201343. https:\/\/doi.org\/10.2337\/DCI23-0085","journal-title":"Diabetes Care"},{"issue":"10397","key":"6504_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0140-6736(23)00914-5","volume":"402","author":"AF Walker","year":"2023","unstructured":"Walker AF, Graham S, Maple-Brown L et al (2023) Interventions to address global inequity in diabetes: international progress. Lancet 402(10397):250\u2013264. https:\/\/doi.org\/10.1016\/S0140-6736(23)00914-5","journal-title":"Lancet"},{"key":"6504_CR54","unstructured":"French National Research Agency (2025) Generic call for proposals \u2013 AAPG 2025. Available from: https:\/\/anr.fr\/en\/call-for-proposals-details\/call\/generic-call-for-proposals-aapg-2025\/. Accessed 28 Feb 2025"},{"key":"6504_CR55","unstructured":"Kuwait Foundation for the Advancement of Sciences (n.d.) International collaborative research. Available from: https:\/\/www.kfas.org\/Offerings\/Scientist-or-Researcher\/International-Collaborative-Research. Accessed 28 Feb 2025"},{"issue":"1","key":"6504_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12961-023-00979-7","volume":"21","author":"T Adam","year":"2023","unstructured":"Adam T, Ralaidovy AH, Ross AL, Reeder JC, Swaminathan S (2023) Tracking global resources and capacity for health research: time to reassess strategies and investment decisions. Health Res Policy Syst 21(1):93. https:\/\/doi.org\/10.1186\/s12961-023-00979-7","journal-title":"Health Res Policy Syst"},{"issue":"8","key":"6504_CR57","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/S42399-021-00896-2","volume":"3","author":"S Momtazmanesh","year":"2021","unstructured":"Momtazmanesh S, Saghazadeh A, Carlos J et al (2021) International scientific collaboration is needed to bridge science to society: USERN2020 consensus statement. SN Compr Clin Med 3(8):1699\u20131703. https:\/\/doi.org\/10.1007\/S42399-021-00896-2","journal-title":"SN Compr Clin Med"},{"key":"6504_CR58","unstructured":"World Young Scientist Summit (n.d.) Young scientists\u2019 summit looks to sustainable future. Available from: https:\/\/www.nature.com\/articles\/d42473-024-00023-4. Accessed 28 Feb 2025"},{"key":"6504_CR59","doi-asserted-by":"publisher","unstructured":"Anonymous (2025) Anger, despair, and defiance from a voice within the US federal research system. BMJ 388. https:\/\/doi.org\/10.1136\/BMJ.R294","DOI":"10.1136\/BMJ.R294"},{"issue":"4","key":"6504_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11892-015-0591-8","volume":"15","author":"D Beran","year":"2015","unstructured":"Beran D (2015) The impact of health systems on diabetes care in low and lower middle income countries. Curr Diab Rep 15(4):1\u201313. https:\/\/doi.org\/10.1007\/S11892-015-0591-8","journal-title":"Curr Diab Rep"},{"issue":"1","key":"6504_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/DCI20-0053","volume":"44","author":"F Hill-Briggs","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA et al (2020) Social determinants of health and diabetes: a scientific review. Diabetes Care 44(1):258. https:\/\/doi.org\/10.2337\/DCI20-0053","journal-title":"Diabetes Care"},{"issue":"6","key":"6504_CR62","doi-asserted-by":"publisher","first-page":"e15089","DOI":"10.1111\/DME.15089","volume":"40","author":"A Bernabe-Ortiz","year":"2023","unstructured":"Bernabe-Ortiz A, Carrillo-Larco RM, Safary E, Vetter B, Lazo-Porras M (2023) Use of continuous glucose monitors in low- and middle-income countries: a scoping review. Diabetic Med 40(6):e15089. https:\/\/doi.org\/10.1111\/DME.15089","journal-title":"Diabetic Med"},{"issue":"4","key":"6504_CR63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1177\/19322968221081216","volume":"17","author":"F Huhn","year":"2023","unstructured":"Huhn F, Lange K, J\u00f6rdening M, Ernst G (2023) Real-world use of continuous glucose monitoring systems among adolescents and young adults with type 1 diabetes: reduced burden, but little interest in data analysis. J Diabetes Sci Technol 17(4):943\u2013950. https:\/\/doi.org\/10.1177\/19322968221081216","journal-title":"J Diabetes Sci Technol"},{"key":"6504_CR64","doi-asserted-by":"publisher","unstructured":"Gao D, Friedman S, Hosler A, Sheridan S, Zhang W, Lin S (2022) Association between extreme ambient heat exposure and diabetes-related hospital admissions and emergency department visits: a systematic review. Hyg Environ Health Adv 4. https:\/\/doi.org\/10.1016\/j.heha.2022.100031","DOI":"10.1016\/j.heha.2022.100031"},{"key":"6504_CR65","doi-asserted-by":"publisher","first-page":"118080","DOI":"10.1016\/J.ECOENV.2025.118080","volume":"294","author":"W Jiang","year":"2025","unstructured":"Jiang W, Zhou H, Xu G, Zhang M, Tung T-H, Luo C (2025) The association between air pollution and three types of diabetes: an umbrella review of systematic reviews and meta-analyses. Ecotoxicol Environ Saf 294:118080. https:\/\/doi.org\/10.1016\/J.ECOENV.2025.118080","journal-title":"Ecotoxicol Environ Saf"},{"key":"6504_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/S00125-025-06406-6","author":"AJM Boulton","year":"2025","unstructured":"Boulton AJM, Jenkins AJ, Makkar B, Mankovsky B, Abera MA, Tesfaye S (2025) Diabetes and natural and man-made disasters: prevention, preparation, response and recovery. Diabetologia. https:\/\/doi.org\/10.1007\/S00125-025-06406-6","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"6504_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/DOM.15470","volume":"26","author":"O Ebekozien","year":"2024","unstructured":"Ebekozien O, Fantasia K, Farrokhi F, Sabharwal A, Kerr D (2024) Technology and health inequities in diabetes care: how do we widen access to underserved populations and utilize technology to improve outcomes for all? Diabetes Obes Metab 26(Suppl 1):3\u201313. https:\/\/doi.org\/10.1111\/DOM.15470","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"6504_CR68","doi-asserted-by":"publisher","first-page":"101213","DOI":"10.1016\/J.XCRM.2023.101213","volume":"4","author":"Z Guan","year":"2023","unstructured":"Guan Z, Li H, Liu R et al (2023) Artificial intelligence in diabetes management: advancements, opportunities, and challenges. Cell Rep Med 4(10):101213. https:\/\/doi.org\/10.1016\/J.XCRM.2023.101213","journal-title":"Cell Rep Med"},{"issue":"4","key":"6504_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/S41574-021-00621-Y","volume":"18","author":"M Fralick","year":"2022","unstructured":"Fralick M, Jenkins AJ, Khunti K, Mbanya JC, Mohan V, Schmidt MI (2022) Global accessibility of therapeutics for diabetes mellitus. Nat Rev Endocrinol 18(4):199\u2013204. https:\/\/doi.org\/10.1038\/S41574-021-00621-Y","journal-title":"Nat Rev Endocrinol"},{"key":"6504_CR70","unstructured":"WHO (n.d.) Improving access to essential medicines. Available from: https:\/\/www.who.int\/westernpacific\/activities\/improving-access-to-essential-medicines. Accessed 28 Feb 2025"},{"issue":"1","key":"6504_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.34172\/HPP.2023.05","volume":"13","author":"VK Chattu","year":"2023","unstructured":"Chattu VK, Singh B, Pattanshetty S, Reddy S (2023) Access to medicines through global health diplomacy. Health Promot Perspect 13(1):40. https:\/\/doi.org\/10.34172\/HPP.2023.05","journal-title":"Health Promot Perspect"},{"key":"6504_CR72","unstructured":"WHO Eastern Mediterranean Region (n.d.) Essential medicines and pharmaceutical policies. Available from: https:\/\/www.emro.who.int\/essential-medicines\/strategy-access\/. Accessed 28 Feb 2025"},{"key":"6504_CR73","unstructured":"WHO (n.d.) Noncommunicable disease surveillance, monitoring and reporting: STEPwise approach to NCD risk factor surveillance (STEPS). Available from:https:\/\/www.who.int\/teams\/noncommunicable-diseases\/surveillance\/systems-tools\/steps. Accessed 28 Feb 2025"},{"key":"6504_CR74","unstructured":"WHO (2023) WHO model list of essential medicines - 23rd list, 2023. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.02. Accessed 14 May 2025"},{"key":"6504_CR75","doi-asserted-by":"publisher","unstructured":"Conway RB, Snell-Bergeon J, Honda-Kohmo K et al (2024) Disparities in diabetes technology uptake in youth and young adults with type 1 diabetes: a global perspective. J Endocr Soc 9(1). https:\/\/doi.org\/10.1210\/jendso\/bvae210","DOI":"10.1210\/jendso\/bvae210"},{"issue":"7","key":"6504_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/S11892-022-01470-3","volume":"22","author":"S Agarwal","year":"2022","unstructured":"Agarwal S, Simmonds I, Myers AK (2022) The use of diabetes technology to address inequity in health outcomes: limitations and opportunities. Curr Diab Rep 22(7):275. https:\/\/doi.org\/10.1007\/S11892-022-01470-3","journal-title":"Curr Diab Rep"},{"issue":"11","key":"6504_CR77","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2337\/DC19-0345","volume":"42","author":"L Van Den Boom","year":"2019","unstructured":"Van Den Boom L, Karges B, Auzanneau M et al (2019) Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care 42(11):2050\u20132056. https:\/\/doi.org\/10.2337\/DC19-0345","journal-title":"Diabetes Care"},{"issue":"2","key":"6504_CR78","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/DIA.2018.0384","volume":"21","author":"NC Foster","year":"2019","unstructured":"Foster NC, Beck RW, Miller KM et al (2019) State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018. Diabetes Technol Ther 21(2):66\u201372. https:\/\/doi.org\/10.1089\/DIA.2018.0384","journal-title":"Diabetes Technol Ther"},{"issue":"10397","key":"6504_CR79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA et al (2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402(10397):203\u2013234. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6","journal-title":"Lancet"},{"issue":"3","key":"6504_CR80","doi-asserted-by":"publisher","first-page":"e2004","DOI":"10.1002\/HSR2.2004","volume":"7","author":"MJ Hossain","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR (2024) Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep 7(3):e2004. https:\/\/doi.org\/10.1002\/HSR2.2004","journal-title":"Health Sci Rep"},{"key":"6504_CR81","doi-asserted-by":"publisher","unstructured":"The Lancet (2023) Diabetes: a defining disease of the 21st century. Lancet 401(10394):2087. https:\/\/doi.org\/10.1016\/S0140-6736(23)01296-5","DOI":"10.1016\/S0140-6736(23)01296-5"},{"issue":"3","key":"6504_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/J.ECL.2021.05.002","volume":"50","author":"D Duan","year":"2021","unstructured":"Duan D, Kengne AP, Echouffo-Tcheugui JB (2021) Screening for diabetes and prediabetes. Endocrinol Metab Clin North Am 50(3):369\u2013385. https:\/\/doi.org\/10.1016\/J.ECL.2021.05.002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10384","key":"6504_CR83","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","volume":"401","author":"EW Gregg","year":"2023","unstructured":"Gregg EW, Buckley J, Ali MK et al (2023) Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. Lancet 401(10384):1302\u20131312. https:\/\/doi.org\/10.1016\/S0140-6736(23)00001-6","journal-title":"Lancet"},{"issue":"3","key":"6504_CR84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/J.MJAFI.2020.03.002","volume":"76","author":"JS Thakur","year":"2020","unstructured":"Thakur JS, Paika R, Singh S (2020) Burden of noncommunicable diseases and implementation challenges of National NCD Programmes in India. Med J Armed Forces India 76(3):261\u2013267. https:\/\/doi.org\/10.1016\/J.MJAFI.2020.03.002","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"6504_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-020-05951-7\/TABLES\/4","volume":"20","author":"RE Hawkes","year":"2020","unstructured":"Hawkes RE, Cameron E, Cotterill S, Bower P, French DP (2020) The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience. BMC Health Serv Res 20(1):1\u201312. https:\/\/doi.org\/10.1186\/S12913-020-05951-7\/TABLES\/4","journal-title":"BMC Health Serv Res"},{"issue":"S3","key":"6504_CR86","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/S0020-7292(15)30033-3","volume":"131","author":"M Hod","year":"2015","unstructured":"Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstetr 131(S3):S173\u2013S211. https:\/\/doi.org\/10.1016\/S0020-7292(15)30033-3","journal-title":"Int J Gynecol Obstetr"},{"issue":"1","key":"6504_CR87","doi-asserted-by":"publisher","first-page":"1326687","DOI":"10.1080\/16549716.2017.1326687","volume":"10","author":"LN Allen","year":"2017","unstructured":"Allen LN (2017) Financing national non-communicable disease responses. Glob Health Action 10(1):1326687. https:\/\/doi.org\/10.1080\/16549716.2017.1326687","journal-title":"Glob Health Action"},{"key":"6504_CR88","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/J.LANEPE.2022.100420","volume":"19","author":"E McManus","year":"2022","unstructured":"McManus E, Meacock R, Parkinson B, Sutton M (2022) Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: an observational study. Lancet Regional Health - Europe 19:100420. https:\/\/doi.org\/10.1016\/J.LANEPE.2022.100420","journal-title":"Lancet Regional Health - Europe"},{"issue":"2","key":"6504_CR89","doi-asserted-by":"publisher","first-page":"e066301","DOI":"10.1136\/BMJOPEN-2022-066301","volume":"13","author":"E Barry","year":"2023","unstructured":"Barry E, Greenhalgh T, Shaw S, Papoutsi C (2023) Explaining the UK\u2019s \u2018high-risk\u2019 approach to type 2 diabetes prevention: findings from a qualitative interview study with policy-makers in England. BMJ Open 13(2):e066301. https:\/\/doi.org\/10.1136\/BMJOPEN-2022-066301","journal-title":"BMJ Open"},{"key":"6504_CR90","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1744-8603-4-3","volume":"4","author":"K Siegel","year":"2008","unstructured":"Siegel K, Venkat KMV (2008) The Unite for Diabetes campaign: overcoming constraints to find a global policy solution. Global Health 4:3. https:\/\/doi.org\/10.1186\/1744-8603-4-3","journal-title":"Global Health"},{"issue":"8055","key":"6504_CR91","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/D41586-025-00704-0","volume":"639","author":"J Nowogrodzki","year":"2025","unstructured":"Nowogrodzki J, Basilio H, Ledford H, Maher B, Witze A (2025) \u201cScientists will not be silenced\u201d: thousands protest Trump research cuts. Nature 639(8055):551\u2013552. https:\/\/doi.org\/10.1038\/D41586-025-00704-0","journal-title":"Nature"},{"issue":"1","key":"6504_CR92","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/S12875-025-02743-Y","volume":"26","author":"J Li","year":"2025","unstructured":"Li J, Xu Z, Zhou H, Li Z, Yuan B (2025) The involvement of specialists in primary healthcare teams for managing diabetes: a systematic review and meta-analysis. BMC Primary Care 26(1):45. https:\/\/doi.org\/10.1186\/S12875-025-02743-Y","journal-title":"BMC Primary Care"},{"issue":"7","key":"6504_CR93","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/DME.12747","volume":"32","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller N, Heller T, Freitag MH et al (2015) Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data. Diabetic Medicine 32(7):951\u2013957. https:\/\/doi.org\/10.1111\/DME.12747","journal-title":"Diabetic Medicine"},{"issue":"4","key":"6504_CR94","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/QMH.0000000000000068","volume":"24","author":"A Peterson","year":"2015","unstructured":"Peterson A, Gudbjornsdottir S, Lofgren UB et al (2015) Collaboratively improving diabetes care in Sweden using a national quality register: successes and challenges - a case study. Qual Manag Health Care 24(4):212\u2013221. https:\/\/doi.org\/10.1097\/QMH.0000000000000068","journal-title":"Qual Manag Health Care"},{"issue":"4","key":"6504_CR95","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/DIACARE.26.4.1270","volume":"26","author":"S Gudbj\u00f6rnsdottir","year":"2003","unstructured":"Gudbj\u00f6rnsdottir S, Cederholm J, Nilsson PM, Eliasson B (2003) The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 26(4):1270\u20131276. https:\/\/doi.org\/10.2337\/DIACARE.26.4.1270","journal-title":"Diabetes Care"},{"key":"6504_CR96","doi-asserted-by":"publisher","first-page":"CD014513","DOI":"10.1002\/14651858.CD014513","volume":"6","author":"KJ Konnyu","year":"2023","unstructured":"Konnyu KJ, Yogasingam S, L\u00e9pine J et al (2023) Quality improvement strategies for diabetes care: effects on outcomes for adults living with diabetes. Cochrane Database Syst Rev 6:CD014513. https:\/\/doi.org\/10.1002\/14651858.CD014513","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"6504_CR97","doi-asserted-by":"publisher","first-page":"e0237585","DOI":"10.1371\/JOURNAL.PONE.0237585","volume":"15","author":"ND Eze","year":"2020","unstructured":"Eze ND, Mateus C, Hashiguchi TCO (2020) Telemedicine in the OECD: an umbrella review of clinical and cost-effectiveness, patient experience and implementation. PLoS One 15(8):e0237585. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0237585","journal-title":"PLoS One"},{"issue":"8","key":"6504_CR98","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","volume":"5","author":"R Atun","year":"2017","unstructured":"Atun R, Davies JI, Gale EAM et al (2017) Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol 5(8):622\u2013667. https:\/\/doi.org\/10.1016\/S2213-8587(17)30181-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10267","key":"6504_CR99","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","volume":"396","author":"JCN Chan","year":"2020","unstructured":"Chan JCN, Lim LL, Wareham NJ et al (2020) The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet 396(10267):2019\u20132082. https:\/\/doi.org\/10.1016\/S0140-6736(20)32374-6","journal-title":"Lancet"},{"issue":"6","key":"6504_CR100","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S2213-8587(22)00072-9","volume":"10","author":"RM Anjana","year":"2022","unstructured":"Anjana RM, Unnikrishnan R, Deepa M et al (2022) Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study. Lancet Diabetes Endocrinol 10(6):430\u2013441. https:\/\/doi.org\/10.1016\/S2213-8587(22)00072-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"6504_CR101","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","volume":"65","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS et al (2022) Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 65(12):1925. https:\/\/doi.org\/10.1007\/s00125-022-05787-2","journal-title":"Diabetologia"},{"issue":"6","key":"6504_CR102","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2337\/DC17-2010","volume":"41","author":"LL Lim","year":"2018","unstructured":"Lim LL, Lau ESH, Kong APS et al (2018) Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis. Diabetes Care 41(6):1312\u20131320. https:\/\/doi.org\/10.2337\/DC17-2010","journal-title":"Diabetes Care"},{"issue":"5","key":"6504_CR103","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2337\/DC17-1795","volume":"41","author":"MO Owolabi","year":"2018","unstructured":"Owolabi MO, Yaria JO, Daivadanam M et al (2018) Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review. Diabetes Care 41(5):1097\u20131105. https:\/\/doi.org\/10.2337\/DC17-1795","journal-title":"Diabetes Care"},{"issue":"4","key":"6504_CR104","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/J.1464-5491.1993.TB00083.X","volume":"10","author":"K Piwernetz","year":"1993","unstructured":"Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M (1993) Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med 10(4):371\u2013377. https:\/\/doi.org\/10.1111\/J.1464-5491.1993.TB00083.X","journal-title":"Diabet Med"},{"issue":"3","key":"6504_CR105","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/IJE\/2.3.221","volume":"2","author":"JM Weddell","year":"1973","unstructured":"Weddell JM (1973) Registers and registries: a review. Int J Epidemiol 2(3):221\u2013228. https:\/\/doi.org\/10.1093\/IJE\/2.3.221","journal-title":"Int J Epidemiol"},{"issue":"12","key":"6504_CR106","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/DCI22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T et al (2022) Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 45(12):3075\u20133090. https:\/\/doi.org\/10.2337\/DCI22-0027","journal-title":"Diabetes Care"},{"issue":"20","key":"6504_CR107","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL et al (2023) Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation 148(20):1606\u20131635. https:\/\/doi.org\/10.1161\/CIR.0000000000001184","journal-title":"Circulation"},{"issue":"11","key":"6504_CR108","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.2337\/DCI19-0003","volume":"42","author":"JCN Chan","year":"2019","unstructured":"Chan JCN, Lim LL, Luk AOY et al (2019) From Hong Kong diabetes register to JADE program to RAMP-DM for data-driven actions. Diabetes Care 42(11):2022\u20132031. https:\/\/doi.org\/10.2337\/DCI19-0003","journal-title":"Diabetes Care"},{"issue":"2","key":"6504_CR109","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.DIABET.2011.09.002","volume":"38","author":"JJ Gagliardino","year":"2012","unstructured":"Gagliardino JJ, Aschner P, Baik SH et al (2012) Patients\u2019 education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab 38(2):128\u2013134. https:\/\/doi.org\/10.1016\/J.DIABET.2011.09.002","journal-title":"Diabetes Metab"},{"issue":"2","key":"6504_CR110","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2213-8587(17)30239-5","volume":"6","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K (2018) Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol 6(2):130\u2013142. https:\/\/doi.org\/10.1016\/S2213-8587(17)30239-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"6504_CR111","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1177\/19322968211070855","volume":"17","author":"A Kieu","year":"2023","unstructured":"Kieu A, King J, Govender RD, \u00d6stlundh L (2023) The benefits of utilizing continuous glucose monitoring of diabetes mellitus in primary care: a systematic review. J Diabetes Sci Technol 17(3):762\u2013774. https:\/\/doi.org\/10.1177\/19322968211070855","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"6504_CR112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2337\/CD23-AS01","volume":"41","author":"H Feldman","year":"2023","unstructured":"Feldman H, ElSayed NA, McCoy RG et al (2023) Standards of care in diabetes\u20142023 abridged for primary care providers. Clin Diabetes 41(1):4\u201331. https:\/\/doi.org\/10.2337\/CD23-AS01","journal-title":"Clin Diabetes"},{"key":"6504_CR113","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/JHL.S394088","volume":"15","author":"JF Donohue","year":"2023","unstructured":"Donohue JF, Elborn JS, Lansberg P et al (2023) Bridging the \u201cKnow-Do\u201d gaps in five non-communicable diseases using a common framework driven by implementation science. J Healthc Leadersh 15:103. https:\/\/doi.org\/10.2147\/JHL.S394088","journal-title":"J Healthc Leadersh"},{"issue":"4","key":"6504_CR114","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/J.KINT.2016.11.023","volume":"91","author":"J Oellgaard","year":"2017","unstructured":"Oellgaard J, G\u00e6de P, Rossing P, Persson F, Parving HH, Pedersen O (2017) Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. Kidney Int 91(4):982\u2013988. https:\/\/doi.org\/10.1016\/J.KINT.2016.11.023","journal-title":"Kidney Int"},{"issue":"5","key":"6504_CR115","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMOA021778","volume":"348","author":"P G\u00e6de","year":"2003","unstructured":"G\u00e6de P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348(5):383\u2013393. https:\/\/doi.org\/10.1056\/NEJMOA021778","journal-title":"N Engl J Med"},{"issue":"7","key":"6504_CR116","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/S13300-024-01595-6","volume":"15","author":"N Alonso-Carril","year":"2024","unstructured":"Alonso-Carril N, Rodriguez-Rodr\u00edguez S, Quir\u00f3s C et al (2024) Could online education replace face-to-face education in diabetes? A systematic review. Diabetes Ther 15(7):1513\u20131524. https:\/\/doi.org\/10.1007\/S13300-024-01595-6","journal-title":"Diabetes Ther"},{"issue":"5","key":"6504_CR117","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361\u2013369. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"6504_CR118","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/S00125-009-1352-5","volume":"52","author":"S Del Prato","year":"2009","unstructured":"Del Prato S (2009) Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia 52(7):1219\u20131226. https:\/\/doi.org\/10.1007\/S00125-009-1352-5","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"6504_CR119","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.2337\/dc24-S009","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR et al (2024) 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024. Diabetes Care 47(Suppl 1):S158\u2013S178. https:\/\/doi.org\/10.2337\/dc24-S009","journal-title":"Diabetes Care"},{"key":"6504_CR120","first-page":"606","volume":"9","author":"WY So","year":"2003","unstructured":"So WY, Tong PCY, Ko GTC et al (2003) Effects of protocol-driven care versus usual outpatient clinic care on survival rates in patients with type 2 diabetes - PubMed. Am J Manag Care 9:606\u2013615","journal-title":"Am J Manag Care"},{"issue":"6","key":"6504_CR121","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/DC13-0512","volume":"36","author":"I Raz","year":"2013","unstructured":"Raz I, Riddle MC, Rosenstock J et al (2013) Personalized management of hyperglycemia in type 2 diabetes: reflections from a diabetes care editors\u2019 expert forum. Diabetes Care 36(6):1779. https:\/\/doi.org\/10.2337\/DC13-0512","journal-title":"Diabetes Care"},{"issue":"12","key":"6504_CR122","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-8587(24)00320-6","volume":"12","author":"M Bergman","year":"2024","unstructured":"Bergman M, Abdul-Ghani M, Chan J et al (2024) Staging schema for early diagnosis of prediabetes. Lancet Diabetes Endocrinol 12(12):873\u2013876. https:\/\/doi.org\/10.1016\/S2213-8587(24)00320-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"6504_CR123","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/S12170-011-0172-6","volume":"5","author":"JCN Chan","year":"2011","unstructured":"Chan JCN, So W, Ma RCW, Tong PCY, Wong R, Yang X (2011) The complexity of vascular and non-vascular complications of diabetes: the Hong Kong diabetes registry. Curr Cardiovasc Risk Rep 5(3):230\u2013239. https:\/\/doi.org\/10.1007\/S12170-011-0172-6","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"7","key":"6504_CR124","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41591-024-03032-4","volume":"30","author":"WT Cefalu","year":"2024","unstructured":"Cefalu WT, Franks PW, Rosenblum ND et al (2024) A global initiative to deliver precision health in diabetes. Nat Med 30(7):1819\u20131822. https:\/\/doi.org\/10.1038\/s41591-024-03032-4","journal-title":"Nat Med"},{"issue":"11","key":"6504_CR125","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S2213-8587(22)00274-1","volume":"10","author":"JC Katte","year":"2022","unstructured":"Katte JC, Sibomana L, Hapunda G, Cikomola JC, Abidha CA (2022) Diabetes in sub-Saharan Africa: what are the next steps? Lancet Diabetes Endocrinol 10(11):766\u2013768. https:\/\/doi.org\/10.1016\/S2213-8587(22)00274-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6504_CR126","unstructured":"European Diabetes Forum (n.d.) Five priorities for advancing integrated care. Available from: https:\/\/www.eudf.org\/strategic-forums\/recommendations\/integrated-care\/. Accessed 28 Feb 2025"},{"issue":"1","key":"6504_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13643-020-01377-8\/TABLES\/7","volume":"9","author":"M Werfalli","year":"2020","unstructured":"Werfalli M, Werfalli M, Raubenheimer PJ et al (2020) The effectiveness of peer and community health worker-led self-management support programs for improving diabetes health-related outcomes in adults in low- and-middle-income countries: a systematic review. Syst Rev 9(1):1\u201319. https:\/\/doi.org\/10.1186\/S13643-020-01377-8\/TABLES\/7","journal-title":"Syst Rev"},{"key":"6504_CR128","unstructured":"Adams C (2024) 10 ways nurses can help patients with diabetes. Available from: https:\/\/diabetesknow.com\/health\/10-ways-nurses-can-help-patients-with-diabetes\/. Accessed 28 Feb 2025"},{"key":"6504_CR129","unstructured":"IDF (n.d.) Resources archive. Available from: https:\/\/idf.org\/about-diabetes\/resources\/?search=curriculum&audience=&type=. Accessed 14 May 2025"},{"key":"6504_CR130","unstructured":"Leicester Diabetes Centre (n.d.) DESMOND Diabetes Education. Available from: https:\/\/www.leicesterdiabetescentre.org.uk\/programmes-blog\/desmond-72xs5. Accessed 14 May 2025"},{"key":"6504_CR131","unstructured":"US Centers for Disease Control and Prevention (n.d.) Diabetes Self-Management Education and Support (DSMES) Toolkit: national standards for DSMES. Available from: https:\/\/www.cdc.gov\/diabetes-toolkit\/php\/about-dsmes\/national-standards-dsmes.html. Accessed 14 May 2025"},{"key":"6504_CR132","unstructured":"Organisation for Economic Co-operation and Development (2020) Realising the potential of primary health care. Available from: https:\/\/www.oecd.org\/en\/publications\/realising-the-potential-of-primary-health-care_a92adee4-en.html. Accessed 28 Feb 2025"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06504-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:04:11Z","timestamp":1760713451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06504-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":132,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6504"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06504-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The EASD Global Council includes the following members: Francesco Giorgino (chair), Fawaz Alzaid, Juliana C. N. Chan, Anca Pantea Stoian, Linong Ji, William Lumu, Didac Mauricio, Helard Manrique, Banshi Saboo, Peter Senior, Daisuke Yabe, Sophia Zoungas, Manuela Meireles and Leszek Czupryniak (advisor).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"This work was supported by the EASD. PAS is supported by the Alberta Academic Medicine Health Services Program and the Charles A. Allard Chair in Diabetes Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"FG reports receiving grants from Eli Lilly and Roche Diabetes Care; consulting fees from Eli Lilly and Novo Nordisk and support for attending meetings or for travel from AstraZeneca, Boehringer Ingelheim, Eli Lilly, LifeScan, Merck Sharp & Dohme, Medtronic, Novo Nordisk, Roche Diabetes Care and Sanofi-Aventis. FG has participated on advisory boards for AstraZeneca, Biomea, Boehringer Ingelheim, Eli Lilly, LifeScan, Merck Sharp & Dohme, MedImmune, Medtronic, Novo Nordisk, Roche Diabetes Care and Sanofi-Aventis. FG is Senior Vice-President of the EASD\/European Foundation for the Study of Diabetes (EFSD) (unpaid). APS reports participating on advisory boards for Amgen, AstraZeneca, Eli Lilly, Merck, Medtronic, MSD, Novo Nordisk, Roche Diabetes and Sanofi and in the CREDANCE, REIMAGINE 2 and ZEUS research\/clinical studies. APS has received fees for meetings, travel or lectures from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Egis, Coca-Cola, Medtronic, Medochemie, Novo Nordisk, Novartis, Merck, MSD, Servier and Sanofi. She is Vice-President of the Romanian Committee of Diabetes, Nutrition, and Metabolic Diseases (unpaid) and Vice-President of Central European Association of Diabetes (CEDA) (unpaid). JCNC reports receiving grants (through institutions) and\/or honoraria for consultancy or giving lectures from Abbott, Applied Therapeutics, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Eli Lilly, Hua Medicine, Merck, Novo Nordisk, Powder Pharmaceuticals, Roche, Sanofi, Servier and ZP Therapeutics. She is the Chief Executive Officer (pro bono) of the Asia Diabetes Foundation, which developed the web-based JADE platform for implementation of data-driven diabetes care. She is a co-inventor of patents owned by the Chinese University of Hong Kong on biomarkers and models for predicting diabetes and its complications. She is a co-founder of GemVCare, a technology company, with partial support from the Hong Kong Government, which uses biogenetic markers and information technology to implement precision diabetes care and prevention through partnerships. LJ reports receiving consulting or lecture fees from Eli Lilly, Novo Nordisk, Merck, Bayer, Sanofi-Aventis, MSD, AstraZeneca, Boehringer Ingelheim, Abbott, Fosun Pharma, Innovent Biologics, Gan & Lee Pharmaceuticals, Sinocare and Sibionics. HM reports receiving lecture fees from Novo Nordisk. DM has received advisory board and\/or speaking fees from AB-Biotics, Abbott, Almirall, Amarna, Amgen, AstraZeneca, Ferrer, Gilead, Lilly, Medtronic, Menarini, MSD, Novo Nordisk and Sanofi. PAS has received speaker and consulting fees from Abbott, Bayer, Dexcom, GSK, Insulet, Novo Nordisk, Vertex and Yposmed. His institution has received grant support from Bayer, the Canadian Institutes of Health Research (CIHR), Brain Canada, Breakthrough T1D and Novo Nordisk. He is a past chair of Diabetes Canada. He serves in leadership roles in Diabetes Action Canada and CanScreen T1D. DY has received clinically commissioned\/joint research grants from Novo Nordisk, Ono Pharmaceutical, Taisho Pharmaceutical, Terumo and Arkay. DY has also received consulting or speaker fees from Sumitomo Dainippon Pharma, Boehringer Ingelheim, Astellas Pharma, MSD, Novo Nordisk, Ono Pharmaceutical, Eli Lilly and Takeda Pharmaceuticals. SZ reports previous payments to her institution (Monash University) from AstraZeneca, Boehringer Ingelheim, CSL Seqirus, Eli Lilly Australia, Moderna, MSD Australia, Sanofi and Novo Nordisk for participation in advisory and educational meetings. CM serves or has served on the advisory panel for Novo Nordisk, Sanofi, Eli Lilly, Novartis, Dexcom, Boehringer Ingelheim, Bayer, Roche, Abbott, Medtronic, Insulet, Biomea Fusion, SAB Bio and Vertex. Financial compensation for these activities has been received by KU Leuven. KU Leuven has received research support for CM from Medtronic, Novo Nordisk and Sanofi. CM serves or has served on the speaker\u2019s bureau for Novo Nordisk, Sanofi, Eli Lilly, Medtronic, Dexcom, Insulet, Abbott, Vertex and Boehringer Ingelheim. Financial compensation for these activities has been received by KU Leuven. CM is President of the EASD. All external support for EASD can be found at . The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}